BRAF: the first prevalent oncogene target to show single-agent responsiveness

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
626 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Feb 14, 2011

Keith Flaherty, MD's lecture at STO Annual Meeting 2010
In metastatic colon cancer with BRAF V600E mutations, the spectrum of response is more heterogeneous and suggests that the repertoire of concomitant oncogene and tumor suppressor gene alterations will influence response to targeted therapy across various

Category:

Education

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more